Screener
Phathom Pharmaceuticals, Inc. PHAT Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Phathom Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Phathom Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 7:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324867
FAQ
- What is Phathom Pharmaceuticals, Inc.'s shares (diluted)?
- Phathom Pharmaceuticals, Inc. (PHAT) reported shares (diluted) of 83.7M in Q2 2026.
- How has Phathom Pharmaceuticals, Inc.'s shares (diluted) changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s shares (diluted) increased by 15.6% year-over-year, from 72.5M to 83.7M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Phathom Pharmaceuticals, Inc.'s shares (diluted) has grown at a 18.5% compound annual growth rate (CAGR), from 147.2M to 290.8M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Phathom Pharmaceuticals, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude